June 29, 2021 -- Boston Children's Hospital and cell and gene therapy accelerator ElevateBio have inked a five-year collaboration to develop cell and gene therapies for patients.
Under the deal, Boston Children's and ElevateBio will form multiple cell and gene therapy companies together and provide Boston Children's researchers access to the company's technologies, manufacturing, and expertise, according to the institution. What's more, the researchers will also be guaranteed dedicated viral vector manufacturing space at ElevateBio's BaseCamp research and development manufacturing center.
In addition, ElevateBio will commit to sponsored research agreements with Boston Children's investigators as part of the company formation process, the hospital said.
Copyright © 2021 scienceboard.net
Member Rewards
Earn points for contributing to market research. Redeem your points for merchandise, travel, or even to help your favorite charity.
Research Topics
Interact with an engaged, global community of your peers who come together to discuss their work and opportunities.
Conferences
Connect
